Add a note about this bill. Your note is for you and will not be shared with anyone.
Because you are a member of panel , your positions on legislation and notes below will be shared with the panel administrators. (More Info)
Americans overspend by an estimated $135 million on prescriptions through their insurance, in cases when they would cost less out of pocket. Yet pharmacists are often under gag orders from telling customers about that discrepancy.
A new bill introduced in the Senate would end this practice.
A “pharmacy gag clause” is a tactic under which a pharmacist may not inform customers which of the two options would cost less for a certain product: using their health insurance or paying fully out of pocket.
These clauses are usually instituted by an insurer or pharmacy benefit manager (PBM), the most famous of which include CVS Health, Express Scripts, or United Health. They’re put in for cases in which most consumers would save money by paying out of pocket — if only …
Sponsor. Senator for Maine. Republican.
Read Text »Enacted — Signed by the President on Oct 10, 2018
This bill was enacted after being signed by the President on October 10, 2018.
Pub.L. 115-263 Cosponsors25 Cosponsors (14 Democrats, 10 Republicans, 1 Independent)
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Jul 25, 2018 Ordered ReportedA committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
Sep 17, 2018 Passed Senate (House next)The bill was passed in a vote in the Senate. It goes to the House next.
Sep 25, 2018 Passed HouseThe bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made.
Oct 10, 2018 Enacted — Signed by the PresidentThe President signed the bill and it became law.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 2554. This is the one from the 115 th Congress.
This bill was introduced in the 115 th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
We recommend the following MLA -formatted citation when using the information you see here in academic work:
GovTrack.us. (2024). S. 2554 — 115th Congress: Patient Right to Know Drug Prices Act. Retrieved from https://www.govtrack.us/congress/bills/115/s2554
“S. 2554 — 115th Congress: Patient Right to Know Drug Prices Act.” www.GovTrack.us. 2018. September 18, 2024
Patient Right to Know Drug Prices Act, Pub. L. No. 115-263, S. 2554, 115th Cong. (2018).
|url=https://www.govtrack.us/congress/bills/115/s2554
|title=S. 2554 (115th)
|accessdate=September 18, 2024
|author=115th Congress (2018)
|date=March 14, 2018
|work=Legislation
|publisher=GovTrack.us
|quote=Patient Right to Know Drug Prices Act
>>
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
GovTrack helps everyone learn about and track the activities of the United States Congress. Launched more than 20 years ago, we’re one of the oldest government transparency and accountability websites on the Internet.
This is a project of Civic Impulse, LLC. GovTrack.us is not a government website.
